Organizational changes encouraged for safer prescribing

July 17, 2017

(HealthDay)—Organizational changes are recommended by primary care physicians to support safer prescribing, according to a study published in the July/August issue of the Annals of Family Medicine.

Katharine A. Wallis, M.B.Ch.B., Ph.D., from the University of Auckland in New Zealand, and colleagues identified potential physician participants using a snowball sampling technique. Emergent themes were identified from 24 semi-structured interventions that were recorded, transcribed, and analyzed.

The researchers note that physicians described swimming against the tide of patient expectations, the culture of prescribing, and organizational constraints. Deprescribing was associated with inherent risks for themselves and , and indicated a sense of vulnerability. A sense of duty to do what was right for the patient was the only incentive for deprescribing. Targeted funding for annual medicines review, computer prompts, improved between-prescriber information flow, improved access to expert advice and user-friendly decision support, increased availability of non-pharmaceutical therapies, and enhanced patient engagement in medicines management were recommended organizational changes to support safer prescribing.

"Regulations and policies should be designed to physicians in practicing according to their professional ethical values," the authors write.

Explore further: Support for financial penalties up with emphasis on patient harms

More information: Abstract
Full Text

Related Stories

Support for financial penalties up with emphasis on patient harms

June 21, 2017
(HealthDay)—Physicians who receive information about patient harms are more likely to support financial penalties targeting inappropriate antibiotic prescribing, according to a research letter published online June 20 in ...

Primary care work environment affects nurse practitioners

January 14, 2014
(HealthDay)—The organizational climate in primary care settings influences the professional practice of nurse practitioners (NPs), according to research published in the November issue of the Journal of Professional Nursing.

Doctors should question the value of most heavily promoted drugs

May 2, 2017
Top promoted drugs are less likely than top selling and top prescribed drugs to be effective, safe, affordable, novel, and represent a genuine advance in treating a disease, argue US researchers in The BMJ today.

Prescription drug monitoring programs offer multiple benefits

July 3, 2015
(HealthDay)—Prescription Drug Monitoring Programs (PDMPs), frequently utilized by emergency medicine physicians and designed to help identify patients who "doctor shop" for prescriptions, are used to guide clinical decisions ...

Cardio risks need evaluation before prescribing statins

March 15, 2013
(HealthDay)—Physicians may not adequately consider a patient's cardiovascular risk when prescribing statins as preventive therapy, according to a research letter published online March 11 in JAMA Internal Medicine.

Time-pressed physicians spend significantly more time on computer than on direct patient interaction

January 30, 2017
Internal medicine physicians at a Swiss teaching hospital frequently worked overtime and spent about 3 times as much time using a computer as they did on patients. Most of their time at work was spent on activities indirectly ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.